>

Our article describing the role of ASXL1 mutations in myeloid malignancies and leukemia has been published and highlighted on the cover of Cancer Cell.
BioTechniques.com spoke with leaders in the field including Prof. Mazhar Adli about the current bottlenecks and developing technologies in epigenetics and epigenomics.
Our Nature Protocols paper (Adli&Bernstein, Nature Protocols, 2011) was covered by Genomeweb.com and they spoke with Prof. Mazhar Adli about the development and potential applications of the Nano-ChIP-Seq technology.
Our Nature Methods paper (Adli et al., Nature Methods, 2010) was highlighted in the News and Views sections of Nature Methods.